[Gene therapy for breast cancer].
Takahashi
Shunji
S
Department of Clinical Chemotherapy and Gene Therapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research.
Sugimoto
Yoshikazu
Y
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics*; D001943:Breast Neoplasms / Q000628:therapy*; D016207:Cytokines / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D005260:Female; D018014:Gene Transfer Techniques; D041722:Genes, Transgenic, Suicide / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D007378:Interleukins / Q000235:genetics; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000235:genetics; D000099180:Interleukin-24
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D016207:Cytokines; D007378:Interleukins; D016271:Proto-Oncogene Proteins c-myc; D018719:Erb-b2 Receptor Tyrosine Kinases; D016159:Tumor Suppressor Protein p53; D000099180:Interleukin-24; C489427:MYC protein, human